This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genome.
Journal of medical virology · 2024
Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA.
The Journal of biological chemistry · 2021 · first author
Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
PloS one · 2020
Latest funding
- $3,749,969
Pathways to Functional Cure in Chronic Hepatitis B
CIHR · 2024 · Principal investigator
11 publications.
Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genome.
Figueroa GB, D'souza S, Pereira HS, Vasudeva G, Figueroa SB, Robinson ZE, Badmalia MD, Meier-Stephenson V, Corcoran JA, van Marle G, Ni Y, Urban S, Coffin CS, Patel TR
Identification and characterization of a G-quadruplex structure in the pre-core promoter region of hepatitis B virus covalently closed circular DNA.
Meier-Stephenson V, Badmalia MD, Mrozowich T, Lau KCK, Schultz SK, Gemmill DL, Osiowy C, van Marle G, Coffin CS, Patel TR
Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia.
Patel NH, Meier-Stephenson V, Genetu M, Damtie D, Abate E, Alemu S, Aleka Y, Van Marle G, Fonseca K, Coffin CS, Deressa T
Prevalence and molecular characterization of occult hepatitis B virus in pregnant women from Gondar, Ethiopia.
Meier-Stephenson V, Deressa T, Genetu M, Damtie D, Braun S, Fonseca K, Swain MG, van Marle G, Coffin CS
Current approaches for RNA-labelling to identify RNA-binding proteins.
Gemmill D, D'souza S, Meier-Stephenson V, Patel TR
Host Transcription Factors in Hepatitis B Virus RNA Synthesis.
Turton KL, Meier-Stephenson V, Badmalia MD, Coffin CS, Patel TR
Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.
Jayanthan A, Hofmann B, Meier-Stephenson V, Perinpanayagam M, Dunn SE, Boklan J, Trippett TM, Truong TH, Narendran A
Comprehensive Analysis of Hepatitis B Virus Promoter Region Mutations.
Meier-Stephenson V, Bremner WTR, Dalton CS, van Marle G, Coffin CS, Patel TR
DEAD-box helicases: the Yin and Yang roles in viral infections.
Meier-Stephenson V, Mrozowich T, Pham M, Patel TR
The HIV protease inhibitor, nelfinavir, as a novel therapeutic approach for the treatment of refractory pediatric leukemia.
Meier-Stephenson V, Riemer J, Narendran A
Pathways to Functional Cure in Chronic Hepatitis B
Principal investigators: Coffin, Carla S; Ko, Hin Hin; Cooper, Curtis L; Crawley, Angela M; Gehring, Adam J; Jenne, Craig N; Meier-Stephenson, Vanessa
Keywords: Artificial Intelligence (Ai); Flow Cytometry; Functional Cure (Fc); Hepatitis B Virus (Hbv); Human Immunology; Humanized Mouse Liver Model; Liver Disease; Novel Biomarkers; Single Cell Rna Sequencing (Scrnaseq); Woodchuck Hepatitis Virus (Whv) Model
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Vanessa Meier-Stephenson and Vanessa Meier-Stephenson: 11 shared papers
- Guido van Marle and Vanessa Meier-Stephenson: 5 shared papers
- Guido van Marle and Vanessa Meier-Stephenson: 5 shared papers
- Vanessa Meier-Stephenson and Aru Narendran: 3 shared papers
- Aru Narendran and Vanessa Meier-Stephenson: 3 shared papers
- Medicine
- Biochemistry and Molecular Biology
- Pediatrics
Co-authors at University of Calgary, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.